Cite Filings / FULC / 0001085146-22-001221
Feed Companies Filings Check
Sign in
SC 13G

Amended Statement of Ownership

Fulcrum Therapeutics, Inc. · Filed 2022-03-09 · Acc 0001085146-22-001221

Documents 1

  • SC 13G Amended Statement of Ownership , fulc_30922.htm

Around this filing

  • 2022-03-14 3 Initial Statement of Ownership
  • 2022-03-10 8-K Executive or director change
  • 2022-03-10 SC 13G Amended Statement of Ownership
  • 2022-03-09 SC 13G Amended Statement of Ownership
  • 2022-03-03 POS AM Post-effective Amendment for Registration Statement
  • 2022-03-03 S-8 Securities Offered to Employees in Benefit Plans
  • 2022-02-04 SC 13G Amended Statement of Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G · ADAR1 Capital Management, LLC 8.7%
  2. 2026-11-16 SCHEDULE 13G/A · EcoR1 Capital, LLC 8.9%
  3. 2026-11-13 SCHEDULE 13G/A · Nantahala Capital Management, LLC 8.62%
  4. 2026-11-13 SCHEDULE 13G/A · Montanova Capital, LLC 0%
Loading fulc_30922.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…